Articles Tagged with ampio pharmaceuticals

Were you sold investments in Ampio Pharmaceuticals (AMPE) by your Aegis Capital Corp broker? If so, Stoltmann Law Offices would like to speak to you about your investments, as they could be risky and you may lose money. If you did lose money, please call 312-332-4200 to speak to an attorney. Our offices are based in Chicago, Illinois and we help investors recover their financial losses in the Financial Industry Regulatory Authority (FINRA) arbitration forum on a contingency fee basis so we only make money if you recover yours. Please call today as there is a statute of limitations associated with most of these cases. Aegis Capital was the joint booking running manager for AMPE in July 2012 when the company sold additional stock to the public. The stock did not perform well. Brokers who sell securities and stocks such as AMPE to clients are required to disclose all information about the company, as well as take into account a customer’s age, net worth, investment objectives and investment sophistication before recommending said investments. If the broker does not, his or her member firm may be liable for losses.

CNBC
FOX Business
The Wall Street Journal
Bloomberg
CBS
FOX News Channel
USA Today
abc NEWS
DATELINE
npr
Contact Information